Artículo original
Sunitinib versus pazopanib para el tratamiento del carcinoma de células renales metastásico: experiencia en 2 hospitales turcos
Sunitinib versus pazopanib for patients with metastatic renal cell carcinoma: 2 Turkish hospital experience
Leído
1489
Vecesse ha leído el artículo
42
Total PDF
1447
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 10 | 18 | 0 | 18 |
| 2025 9 | 28 | 0 | 28 |
| 2025 8 | 30 | 0 | 30 |
| 2025 7 | 35 | 0 | 35 |
| 2025 6 | 42 | 0 | 42 |
| 2025 5 | 34 | 0 | 34 |
| 2025 4 | 51 | 4 | 55 |
| 2025 3 | 64 | 1 | 65 |
| 2025 2 | 67 | 2 | 69 |
| 2025 1 | 77 | 0 | 77 |
| 2024 12 | 102 | 0 | 102 |
| 2024 11 | 56 | 0 | 56 |
| 2024 10 | 37 | 1 | 38 |
| 2024 9 | 52 | 0 | 52 |
| 2024 8 | 42 | 0 | 42 |
| 2024 7 | 42 | 0 | 42 |
| 2024 6 | 38 | 0 | 38 |
| 2024 5 | 48 | 0 | 48 |
| 2024 4 | 43 | 0 | 43 |
| 2024 3 | 41 | 2 | 43 |
| 2024 2 | 52 | 1 | 53 |
| 2024 1 | 41 | 0 | 41 |
| 2023 12 | 59 | 2 | 61 |
| 2023 11 | 43 | 2 | 45 |
| 2023 10 | 26 | 0 | 26 |
| 2023 9 | 10 | 0 | 10 |
| 2023 8 | 13 | 0 | 13 |
| 2023 7 | 5 | 2 | 7 |
| 2023 6 | 6 | 0 | 6 |
| 2023 5 | 13 | 0 | 13 |
| 2023 4 | 11 | 0 | 11 |
| 2023 3 | 23 | 1 | 24 |
| 2023 2 | 5 | 0 | 5 |
| 2022 1 | 10 | 0 | 10 |
| 2022 12 | 7 | 0 | 7 |
| 2022 11 | 10 | 0 | 10 |
| 2022 10 | 7 | 0 | 7 |
| 2022 9 | 10 | 0 | 10 |
| 2022 8 | 13 | 2 | 15 |
| 2022 7 | 11 | 0 | 11 |
| 2022 6 | 8 | 0 | 8 |
| 2022 5 | 12 | 0 | 12 |
| 2022 4 | 8 | 0 | 8 |
| 2022 3 | 12 | 0 | 12 |
| 2022 2 | 7 | 0 | 7 |
| 2021 1 | 16 | 0 | 16 |
| 2021 12 | 1 | 0 | 1 |
| 2021 11 | 1 | 0 | 1 |
| 2021 4 | 0 | 2 | 2 |
| 2020 9 | 1 | 0 | 1 |
| 2020 8 | 2 | 2 | 4 |
| 2020 6 | 1 | 2 | 3 |
| 2020 5 | 5 | 2 | 7 |
| 2020 4 | 1 | 2 | 3 |
| 2020 3 | 10 | 4 | 14 |
| 2020 2 | 28 | 6 | 34 |
| 2020 1 | 12 | 2 | 14 |
Mostrar todo
